Sartorius Ag (SARTF) Cut to “Hold” at Zacks Investment Research
Sartorius Ag (NASDAQ:SARTF) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Saturday.
According to Zacks, “Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. “
Separately, DZ Bank AG reissued a “sell” rating on shares of Sartorius Ag in a report on Friday, July 21st.
Sartorius Ag (NASDAQ:SARTF) opened at 96.00 on Friday. The firm has a market capitalization of $6.57 billion and a price-to-earnings ratio of 54.45. Sartorius Ag has a one year low of $75.00 and a one year high of $96.00.
TRADEMARK VIOLATION WARNING: This piece was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/09/09/sartorius-ag-sartf-cut-to-hold-at-zacks-investment-research.html.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sartorius Ag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Ag and related companies with MarketBeat.com's FREE daily email newsletter.